CClinicalTrials.gg
Status unknownNCT02952976Updated Apr 25, 2017

Study of Primary Fascial Closure Rate in Patients With Open Abdomen Treated With Abthera Versus Barker Technique

A Phase 3 interventional study of Abthera and Barker in Abdominal Trauma, Abdominal Sepsis and Abdominal Compartment Syndrome, sponsored by Sociedade Brasileira de Atendimento Integrado ao Trauma. Status unknown. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-04-25.

Sponsored by Sociedade Brasileira de Atendimento Integrado ao Trauma · Phase 3, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2017), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Phase 3
Study type
Interventional
Enrollment
94
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study is being done to compare two different Temporary Abdominal Closure methods that could be used in cases like yours. The methods being compared are the Barker's vacuum packing technique (BVPT) and the Open Abdomen Negative Pressure Therapy System (ABThera).

Read the detailed description

This study is being done to compare two different Temporary Abdominal Closure methods that could be used in cases of open abdomen. The methods being compared are the Barker's vacuum packing technique (BVPT) and the Open Abdomen Negative Pressure Therapy System (ABThera). The BVPT will be made up by an internal plastic layer to cover abdominal viscera, a second layer with surgical sponges and a suction drain and will be covered by an adhesive plastic layer. Then the dressing will be connected to the hospital's vacuum system. The ABThera dressing is available commercially.

Study Participants Enrollment will happen at the operating room

Investigator will include in this study patients who have the following indications to laparostomy:

  • Damage control surgery in trauma patients,
  • Patients with abdominal compartment syndrome,
  • Septic shock patients requiring short surgery and inability to close the abdominal cavity.

Signing the consent form will be held in order of preference by:

  1. Patient
  2. Legal representative
  3. Doctor appointed by the hospital that does not participate in the study(only in cases where the urgency of the surgery do not allow contact with the representatives).

    In the latter case the signature of the term should be applied to the legal representative as soon as possible.

    Criteria for inclusion and exclusion:

    Inclusion:

    • Patients with indication of an open abdomen According to the Attending physician (above criteria)

    Exclusion:

    • Pregnancy;
    • Chronic renal impairment,
    • Child-Pugh C,
    • Body index over 40 kg / m2,
    • Uncontrolled bleeding during laparotomy
    • Patients progressing to death within the first 48 hours

    Allocation Concealment and Randomization Randomization will be performed by central online dedicated site in the ratio of 1: 1.

    When a patient is eligible, a surgeon will access the Web site, enter patient's information to know the assigned allocation.

    Variable block size randomization will be utilized stratified by study center

    Assuming a closure rate of 75% in the Abthera arm and 35% in the Control arm, a study with 36 patients in each treatment arm (72 total) would have 90% power to detect such a difference at the 0.05 significance level.

    In order to evaluate closure for 36 patients in each arm, with an estimated loss of 30% either by withdraw or death prior to 48h. So the study will enroll 94 patients (47 in each treatment group) After surgery, patients will be referred to the intensive care unit (ICU). In patients' Barker Group a fenestrated plastic will be used and that will be in contact with viscera followed by four pads with a suction drain and an adhesive finishing layer.

    In ABThera group technique the dressing will be done according to the description and the manufacturer's instructions (Acelity, San Antonio, TX).

    Primary Objective :

    • Fascial closure in 30 days

    Secondary objectives

    • Demographic variables (gender, age, comorbidities, mechanism of injury or disease),
    • Indication of laparostomy,
    • Systolic blood pressure,
    • Amount of fluid drained by the healing of laparostomy,
    • Amount of crystalloid,
    • Amount of hemoconcentrated,
    • APACHE II ICU admission,
    • Length of stay in the ICU,
    • Length of mechanical ventilation,
    • Length of hospital stay,
    • Time to closure
    • Adverse Events
    • Complications
    • Mortality.

    In trauma patients the score Revised Trauma (RTS) and the Injury Severity Score (ISS) will be calculated

    Statistical analysis

    Descriptive variables will be summarized as frequencies and percentages. Continuous variable data will be presented as means and standard deviations or medians and ranges, depending on the distribution.

    The analysis of the qualitative variables will be done through measures of association (chi-square or Fisher 's exact test). The analysis of quantitative variables will be made by means of different tests (parametric and nonparametric) depending on the outcome of the applied normality test

02

Conditions studied

  • Abdominal Trauma
  • Abdominal Sepsis
  • Abdominal Compartment Syndrome

Keywords

  • open abdomen
  • Damage control
  • Abdominal Compartment Syndrome
03

In context

Intraabdominal Infections

133 studies on the registry are indexed under Intraabdominal Infections; 15 are open to participants now.

This study's planned enrollment of 94 is below the median of 144 across 81 interventional studies indexed under Intraabdominal Infections.

Browse Intraabdominal Infections studies →

Lead sponsor

This is the only study on the registry with Sociedade Brasileira de Atendimento Integrado ao Trauma as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients with indication of an open abdomen According to the Attending physician
  • Damage control surgery in trauma patients,
  • Patients with abdominal compartment syndrome,
  • Septic shock patients requiring short surgery and inability to close the abdominal cavity.

Exclusion criteria

Exclusion Criteria:

  • Pregnancy;
  • Chronic renal impairment,
  • Child-Pugh C,
  • Body index over 40 kg / m2,
  • Uncontrolled bleeding during laparotomy
  • Patients progressing to death within the first 48 hours
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
94 participants (estimated)

Study arms

  • Active comparator
    Abthera

    Patients with open abdomen submitted to treatment with the Abthera dressing

    Device: Abthera

  • Active comparator
    Barker

    Patients with open abdomen submitted to treatment with the Baker dressing

    Device: Barker

Interventions

  • DeviceAbthera

    ABThera group technique the dressing will be done according to the description and the manufacturer's instructions (Acelity, San Antonio, TX).

  • DeviceBarker

    In Barker Group a fenestrated plastic will be used and that will be in contact with viscera followed by four pads with a suction drain and an adhesive finishing layer.

06

What researchers measure

Primary outcomes

  1. 30 day fascial closure

    Percentage of facial closure in each arm

    Time frame: 30 day

Secondary outcomes

  1. Mortality

    Percentage of mortality closure in each arm

    Time frame: 30 days

  2. Drainage

    Amount of fluid in ml drained by the dressing

    Time frame: 30 days

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 25, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02952976
Lead sponsor
Sociedade Brasileira de Atendimento Integrado ao Trauma
Responsible party
Diogo De Freitas Valeiro Garcia (MD PhD FACS, Sociedade Brasileira de Atendimento Integrado ao Trauma) — Principal investigator
First posted
Nov 2, 2016
Start date
Jul 1, 2017 (estimated)
Primary completion
Jul 2019 (estimated)
Completion
Dec 2019 (estimated)
Last update
Apr 25, 2017

Study contacts

Diogo Garcia, MD PhD FACS
Contact
diogogarcia@me.com
+5511996131077

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion